scispace - formally typeset
P

Pazit Beckerman

Researcher at Sheba Medical Center

Publications -  8
Citations -  218

Pazit Beckerman is an academic researcher from Sheba Medical Center. The author has contributed to research in topics: Peritoneal dialysis & Renal function. The author has an hindex of 2, co-authored 8 publications receiving 113 citations.

Papers
More filters
Journal ArticleDOI

Loss-of-function mutations of CYP24A1, the vitamin D 24-hydroxylase gene, cause long-standing hypercalciuric nephrolithiasis and nephrocalcinosis.

TL;DR: CYP24A1 mutations should be considered in the differential diagnosis of hypercalciuric nephrolithiasis, especially as many adults are now prescribed supplemental oral vitamin D, and support a recessive mode of inheritance.
Journal ArticleDOI

Acute kidney injury in patients treated with immune checkpoint inhibitors.

Shruti Gupta, +67 more
TL;DR: In this paper, a multivariable logistic regression model was used to identify predictors of ICPi-AKI and its recovery, and the effect of rechallenge versus no re-challenge on survival was estimated.
Journal ArticleDOI

Early Persistent Hyperparathyroidism Post‐Renal Transplantation as a Predictor of Worse Graft Function and Mortality After Transplantation

TL;DR: Persistent hyperparathyroidism (pHPT) is frequently seen after transplantation contributing to post‐transplant complications.
Journal ArticleDOI

Hyperphosphatemia during spontaneous tumor lysis syndrome culminate in severe hypophosphatemia at the time of blast crisis of Phneg CML to acute myelomoncytic leukemia

TL;DR: The mutated p53 protein suggested acting as oncogene in the presented case and possibly affecting phosphor status andpossibly affectingosphor status was the result of imbalance between massive apoptosis of leukemic cells.
Journal ArticleDOI

Effect of Peritoneal Dialysis on Serum Fibrosis Biomarkers in Patients with Refractory Congestive Heart Failure

TL;DR: In refractory CHF patients PD treatment was associated with a reduction in circulating fibrosis markers, and the clinical benefit of PD manifested by improved NYHA functional class and reduced hospitalization rate.